Amphetamine
Sponsors
Virginia Commonwealth University, Yale University, University of California, San Diego, Neurocrine Biosciences, University Hospital, Basel, Switzerland
Conditions
Attention Deficit Disorder With HyperactivityAttention Deficit Hyperactivity DisorderAutism Spectrum DisorderCocaine DependenceEating DisorderHealthyHealthy VolunteersNicotine Dependence
Early Phase 1
Phase 1
Caffeine and Cocaine
CompletedNCT00733993
Start: 2008-04-30End: 2011-10-31Updated: 2017-03-22
A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)
CompletedNCT02959892
Start: 2016-12-05End: 2017-08-23Updated: 2021-03-19
Phase 2
Phase 4
Unknown Phase
Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion Paradigm
CompletedNCT01699607
Start: 2012-06-30End: 2013-07-31Updated: 2020-03-06
Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers
CompletedNCT02348385
Start: 2012-12-31End: 2017-12-31Updated: 2023-03-02
A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
CompletedNCT04132557
Start: 2019-10-09End: 2019-10-25Updated: 2025-06-25